PerpEquities

Top analysts on stock perps · Analyst

Sean Laaman (Morgan Stanley): analyst track record on stock perps

Sean Laaman of Morgan Stanley on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.

Stars4.8★
Success65%
Excess return+15.1%
rank#507
Ratings287
ratings on stock perps21

Track record

TipRanks data via FMP

After buy calls: not enough measured cases yet

Current calls on stock perps

StockCallTargetvs last closeDate
$RVMD Revolution Medicines, Inc.Buy · Initiated$255+23.9%Sep 10, 2026
$EXEL Exelixis, Inc.Hold · Maintained$53.00Aug 6, 2026

Recent ratings

  • Sep 10, 2026 $RVMD: Initiated · Buy · $255 · article
  • Aug 6, 2026 $EXEL: Maintained · Hold · $53.00 · article
  • Jul 23, 2026 $EXEL: Reiterated · Hold · $53.00 · article
  • Jul 6, 2026 $EXEL: Maintained · Hold · $50.00 · article
  • Jun 22, 2026 $EXEL: Maintained · Hold · $50.00 · article
  • May 6, 2026 $EXEL: Maintained · Hold · $50.00 · article
  • Mar 8, 2026 $EXEL: Maintained · Hold · $49.00 · article
  • Mar 2, 2026 $EXEL: Maintained · Hold · $49.00 · article
  • Feb 11, 2026 $EXEL: Maintained · Hold · $49.00 · article
  • Feb 2, 2026 $EXEL: Maintained · Hold · $49.00 · article
  • Jan 8, 2026 $EXEL: Downgraded · Hold · $48.00 · article
  • Dec 5, 2025 $EXEL: Maintained · Buy · $45.00 · article
  • Nov 5, 2025 $EXEL: Maintained · Buy · $45.00 · article
  • Oct 21, 2025 $EXEL: Maintained · Buy · $44.00 · article
  • Sep 17, 2025 $EXEL: Maintained · Buy · $50.00 · article
  • Jul 29, 2025 $EXEL: Maintained · Buy · $46.00 · article
  • Jul 22, 2025 $EXEL: Maintained · Buy · $48.00 · article
  • May 14, 2025 $EXEL: Maintained · Buy · $47.00 · article
  • Mar 26, 2025 $EXEL: Maintained · Buy · $40.00 · article
  • Feb 12, 2025 $EXEL: Maintained · Buy · $40.00 · article

Sean Laaman4.8★ · 65% success · +15.1% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.